Title : Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.

Pub. Date : 2010 Feb 3

PMID : 19909793






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain. LY 379268 brain derived neurotrophic factor Mus musculus
2 By using in situ hybridization and western blotting methods the aim of present study was to analyse the potential regulatory role of selective mGluR2/3 agonist LY379268 treatment on brain derived neurotrophic factor (BDNF) expression in the mouse brain. LY 379268 brain derived neurotrophic factor Mus musculus
3 By using in situ hybridization and western blotting methods the aim of present study was to analyse the potential regulatory role of selective mGluR2/3 agonist LY379268 treatment on brain derived neurotrophic factor (BDNF) expression in the mouse brain. LY 379268 brain derived neurotrophic factor Mus musculus
4 The treatment with LY379268 evidenced a significant upregulation of BDNF mRNA levels in the cerebral cortex and in the hippocampal formation with a peak at 3 h from treatment and its disappearance already at 6 h from treatment. LY 379268 brain derived neurotrophic factor Mus musculus
5 An analysis of dose-effect curve revealed that LY379268 may significantly enhance BDNF mRNA expression already at dose of 0.250 mg/kg b.w. LY 379268 brain derived neurotrophic factor Mus musculus
6 The upregulation of BDNF mRNA expression was followed by a significant increase of BDNF protein levels at 24 h from LY379268 treatment. LY 379268 brain derived neurotrophic factor Mus musculus
7 The upregulation of BDNF mRNA expression was followed by a significant increase of BDNF protein levels at 24 h from LY379268 treatment. LY 379268 brain derived neurotrophic factor Mus musculus
8 These effects of LY379268 treatment on BDNF expression were restricted to neuronal cells and were blocked by the new selective mGlu2/3 receptor antagonist LY341495, suggesting a receptor specificity. LY 379268 brain derived neurotrophic factor Mus musculus